Cargando…

Adverse Effects of COX-2 Inhibitors

Cyclooxygenase-2 selective inhibitors (COXIBs) were developed with the prime object of minimizing gastrointestinal adverse effects, which are seen with the use of traditional nonsteroidal anti-inflammatory drugs (NSAIDs). Their long-term use is limited by the development of hypertension, edema, and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sharma, Jagdish N., Jawad, Najeeba M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	TheScientificWorldJOURNAL 2005
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5936602/ https://www.ncbi.nlm.nih.gov/pubmed/16113940 http://dx.doi.org/10.1100/tsw.2005.82

Ejemplares similares

COX-2 Inhibitors and Gastric Cancer
por: Wang, Zhen, et al.
Publicado: (2014)

Exploring the role of COX-2 in Alzheimer's disease: Potential therapeutic implications of COX-2 inhibitors
por: Moussa, Nathalie, et al.
Publicado: (2023)

A genomic exploration identifies mechanisms that may explain adverse cardiovascular effects of COX-2 inhibitors
por: Brænne, Ingrid, et al.
Publicado: (2017)

Radiolabeled COX-2 Inhibitors for Non-Invasive Visualization of COX-2 Expression and Activity — A Critical Update
por: Laube, Markus, et al.
Publicado: (2013)

Select Dietary Phytochemicals Function as Inhibitors of COX-1 but Not COX-2
por: Li, Haitao, et al.
Publicado: (2013)

Cyclooxygenase (COX) Inhibitors and the Newborn Kidney
por: Smith, Francine G., et al.
Publicado: (2012)

Thiazoles and Thiazolidinones as COX/LOX Inhibitors
por: Liaras, Konstantinos, et al.
Publicado: (2018)

Pharmacology, safety, efficacy and clinical uses of the COX‐2 inhibitor robenacoxib
por: Lees, Peter, et al.
Publicado: (2022)

Cardiovascular and gastrointestinal effects of COX-2 inhibitors and NSAIDs: achieving a balance
por: Borer, Jeffrey S, et al.
Publicado: (2005)

Selective COX-2 Inhibitors: Road from Success to Controversy and the Quest for Repurposing
por: El-Malah, Afaf A., et al.
Publicado: (2022)

Cox-2: where are we in 2003? - Cardiovascular risk and Cox-2 inhibitors
por: Mukherjee, Debabrata, et al.
Publicado: (2003)

Chondroprotective Actions of Selective COX-2 Inhibitors In Vivo: A Systematic Review
por: Timur, Ufuk Tan, et al.
Publicado: (2020)

Reduction in cancer risk by selective and nonselective cyclooxygenase-2 (COX-2) inhibitors
por: Harris, Randall E, et al.
Publicado: (2012)

Cyclooxygenase-2 (COX-2) inhibitors: future therapeutic strategies for epilepsy management
por: Rawat, Chitra, et al.
Publicado: (2019)

Flavonoids: Antiplatelet Effect as Inhibitors of COX-1
por: Zaragozá, Cristina, et al.
Publicado: (2022)

Cyclooxygenase-1 (COX-1) and COX-1 Inhibitors in Cancer: A Review of Oncology and Medicinal Chemistry Literature
por: Pannunzio, Alessandra, et al.
Publicado: (2018)

Selective COX-2 inhibitors, NSAIDs and cardiovascular events – is celecoxib the safest choice?
por: Howes, Laurence Guy
Publicado: (2007)

Practical approaches to minimizing gastrointestinal and cardiovascular safety concerns with COX-2 inhibitors and NSAIDs
por: Scheiman, James M, et al.
Publicado: (2005)

Efficacy and Safety of COX-2 Inhibitors in the Clinical Management of Arthritis: Mini Review
por: Mathew, Sam T., et al.
Publicado: (2011)

COX inhibitors and breast cancer
por: Mazhar, D, et al.
Publicado: (2006)

Cox-2 inhibitors in mandibular third molar surgery
por: Janarthanan, K., et al.
Publicado: (2019)

Molecular docking analysis of COX-2 for potential inhibitors
por: Selvaraj, Jayaraman, et al.
Publicado: (2020)

New horizons in the roles and associations of COX-2 and novel natural inhibitors in cardiovascular diseases
por: Chen, Wujun, et al.
Publicado: (2021)

Design and Synthesis of Imidazopyrazolopyridines as Novel Selective COX-2 Inhibitors
por: Badrey, Mohamed G., et al.
Publicado: (2015)

Potential use of COX-2–aromatase inhibitor combinations in breast cancer
por: Bundred, N J, et al.
Publicado: (2005)

Anaphylaxis to selective COX-2 inhibitors: an unexpected culprit
por: Dias de Castro, Eunice, et al.
Publicado: (2015)

Seizure following the Use of the COX-2 Inhibitor Etoricoxib
por: Arnao, Valentina, et al.
Publicado: (2017)

Severe Cutaneous Adverse Drug Reactions: A Clinicoepidemiological Study
por: Sasidharanpillai, Sarita, et al.
Publicado: (2015)

Recent development on COX-2 inhibitors as promising anti-inflammatory agents: The past 10 years
por: Ju, Zhiran, et al.
Publicado: (2022)

Colorectal Carcinoma, Cyclooxygenases, and COX Inhibitors
por: Ganduri, Vinutna, et al.
Publicado: (2022)

Design, Synthesis, and Evaluation of New Tripeptides as COX-2 Inhibitors
por: Vernieri, Ermelinda, et al.
Publicado: (2013)

Selective COX-2 inhibitor versus non-selective COX-2 inhibitor for the prevention of heterotopic ossification after total hip arthroplasty: A meta-analysis
por: Zhu, Xi-Tian, et al.
Publicado: (2018)

Are All Oral COX-2 Selective Inhibitors the Same? A Consideration of Celecoxib, Etoricoxib, and Diclofenac
por: Walker, Chris
Publicado: (2018)

High COX-2 immunostaining in papillary thyroid carcinoma is associated with adverse survival outcomes
por: Al-Maghrabi, Jaudah, et al.
Publicado: (2022)

Binding Energy Calculation of Patchouli Alcohol Isomer Cyclooxygenase Complexes Suggested as COX-1/COX-2 Selective Inhibitor
por: Raharjo, Sentot Joko, et al.
Publicado: (2014)

Design, synthesis and biological evaluation of new 2-aminothiazole scaffolds as phosphodiesterase type 5 regulators and COX-1/COX-2 inhibitors
por: Hussein, Abdel Haleem M., et al.
Publicado: (2020)

New NSAID Conjugates as Potent and Selective COX-2 Inhibitors: Synthesis, Molecular Modeling and Biological Investigation
por: Bokhtia, Riham M., et al.
Publicado: (2023)

Development of Antioxidant COX-2 Inhibitors as Radioprotective Agents for Radiation Therapy—A Hypothesis-Driven Review
por: Laube, Markus, et al.
Publicado: (2016)

Multifocal Fixed Drug Eruption with COX-2 Inhibitor-Celecoxib
por: Chugh, Shikha, et al.
Publicado: (2013)

Relative Value of the NSAIDs, Including COX-2 Inhibitors and Meloxicam
por: Curtiss, Frederic R.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_otufs604i0sjtbrcd2h49u6ovi